Article Details

GSK-3? and its Unexpected Role in Immunity, Inflammation and Cancer

Abstract

Serena De Matteis¹, Roberta Napolitano¹ and Silvia Carloni¹*

¹Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Italy

Corresponding Author:

Silvia Carloni, Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via Maroncelli 40, 47014 Meldola (FC), Italy. Tel: 0039-0543-739977; Fax: 0039-0543-739221; Email: silvia. carloni@irst.emr.it

Keywords: GSK-3?; Immunity; Cancer

Abstract

Glycogen Synthase Kinase-3β (GSK-3β) is a key component of a complex array of cellular processes. Several mechanisms are involved in controlling its activity, including phosphorylation, protein complex formation and sub cellular distribution. Aberrant GSK-3β action has been implicated in many diseases and disorders, such as cancer, heart disease, metabolic and neurological disorders. More recently, GSK-3β has been identified as a crucial regulator of the balance between pro and anti-inflammatory cytokine production. This review will highlight the immunological importance of GSK-3β and the latest discoveries that led to the identification of a new central role of GSK-3β in tumor immunity.

Citation

De Matteis S, Napolitano R and Carloni S. GSK-3β and its Unexpected Role in Immunity, Inflammation and Cancer. SM J Hematol Oncol. 2016; 1(1): 1001.

Download PDF

Received: November 04, 2015

Accepted: April 25, 2016

Published: May 06, 2016